Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap13.04B
Enterprise Value13.02B
P/E Ratio36.55
PEG Ratio-0.54
Price/Sales Ratio3.85
Price/Book Ratio1.17
Enterprise/Revenue4.03
Enterprise/EBITDA21.46

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.11
Operating Margin0.13
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.03

Income Statement

Revenue2.63B
Revenue/Share2.63
Gross Profit1.09B
EBITDA660.62M
Net Income419.27M
Diluted EPS0.44

Balance Sheet

Total Cash1.07B
Total Cash/Share1.14
Total Debt1.27B
Total Debt/Equity0.16
Current Ratio3.04
Book Value Per Share8.58

Price History

52-Week Change-43.9
52-Week High17.86
52-Week Low8.54
Moving Average 50 Days10.21
Moving Average 200 Days12.26

Statistics

Average Volume13.17M
Shares Outstanding950.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.06
Last Split Factor1952679:1000000
Last Split DateJuly 27, 2020
AD